COVID-19 vaccination perception and uptake among cancer patients in Guangzhou, China

References

• WHO. Statement on the second meeting of the International Health Regulations. Emergency committee regarding the outbreak of novel coronavirus (2019-nCov); 2005. https://www.who.int/news/item/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-2005-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-2019-ncov.
   Google Scholar
• Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, Li Q, Jiang C, Zhou Y, Liu S, et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020;81(2):1–8. doi:10.1016/j.jinf.2020.04.021.
   PubMed Web of Science ®Google Scholar
• Johns Hopkins University and Medicine. COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). https://coronavirus.jhu.edu/map.html.
   Google Scholar
• Kim L, Garg S, O’Halloran A, Whitaker M, Pham H, Anderson EJ, Armistead I, Bennett NM, Billing L, Como-Sabetti K, et al. Risk factors for intensive care unit admission and in-hospital mortality among hospitalized adults identified through the US coronavirus disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET). Clin Infect Dis. 2021 May 4;72(9):e206–e214. doi:10.1093/cid/ciaa1012.
   PubMed Web of Science ®Google Scholar
• Parohan M, Yaghoubi S, Seraji A, Javanbakht MH, Sarraf P, Djalali M. Risk factors for mortality in patients with coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. Aging Male. 2020;23(5):1416–1424. doi:10.1080/13685538.2020.1774748.
   PubMed Web of Science ®Google Scholar
• Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, Li P, Zhou Y, Lin Y-F, Duan Q, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. J Infect. 2020;80(6):656–665. doi:10.1016/j.jinf.2020.03.041.
   PubMed Web of Science ®Google Scholar
• Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335–337. doi:10.1016/s1470-2045(20)30096-6.
   PubMed Web of Science ®Google Scholar
• Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, Shete S, Hsu C-Y, Desai A, de Lima Lopes G, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. The Lancet. 2020 June 20;395(10241):1907–1918. doi:10.1016/s0140-6736(20)31187-9.
   PubMed Web of Science ®Google Scholar
• Saini KS, Tagliamento M, Lambertini M, McNally R, Romano M, Leone M, Curigliano G, de Azambuja E. Mortality in patients with cancer and coronavirus disease 2019: a systematic review and pooled analysis of 52 studies. Eur J Cancer. 2020;139:43–50. doi:10.1016/j.ejca.2020.08.011.
   PubMed Web of Science ®Google Scholar
• Hodgson SH, Mansatta K, Mallett G, Harris V, Emary KRW, Pollard AJ. What defines an efficacious COVID-19 vaccine? a review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2. Lancet Infect Dis. 2021;21(2):e26–e35. doi:10.1016/s1473-3099(20)30773-8.
   PubMed Web of Science ®Google Scholar
• Chung JY, Thone MN, Kwon YJ. COVID-19 vaccines: the status and perspectives in delivery points of view. Adv Drug Deliv Rev. 2021;170:1–25. doi:10.1016/j.addr.2020.12.011.
   PubMed Web of Science ®Google Scholar
• COVID19 Vaccine Tracker Team. COVID-19 vaccine development and approvals tracker. [ accessed 2022 Jan 12. https://covid19.trackvaccines.org/country/china/.
   Google Scholar
• National Health Commission. 2021. https://baijiahao.baidu.com/s?id=1716933380465042951&wfr=spider&for=pc.
   Google Scholar
• National Health Commission. 2021. http://news.china.com.cn/2021-11/30/content_77902447.html.
   Google Scholar
• Ribas A, Sengupta R, Locke T, Zaidi SK, Campbell KM, Carethers JM, Jaffee EM, Wherry EJ, Soria J-C, D’Souza G, et al. Priority COVID-19 vaccination for patients with cancer while vaccine supply is limited. Cancer Discov. 2021;11(2):233–236. doi:10.1158/2159-8290.Cd-20-1817.
   PubMed Web of Science ®Google Scholar
• Desai A, Gainor JF, Hegde A, Schram AM, Curigliano G, Pal S, Liu SV, Halmos B, Groisberg R, Grande E, et al. COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials. Nat Rev Clin Oncol. 2021;18(5):313–319. doi:10.1038/s41571-021-00487-z.
   PubMed Web of Science ®Google Scholar
• National Bureau of Disease Control and Prevention. COVID-19 vaccination technical guidelines. 1st ed. 2021. http://www.nhc.gov.cn/jkj/s3582/202103/c2febfd04fc5498f916b1be080905771.shtml.
   Google Scholar
• Hong J, Xu X-W, Yang J, Zheng J, Dai S-M, Zhou J, Zhang Q-M, Ruan Y, Ling C-Q. Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: a cross-sectional survey. J Integr Med. 2022;20(1):34–44. doi:10.1016/j.joim.2021.10.004.
   PubMedGoogle Scholar
• Barrière J, Gal J, Hoch B, Cassuto O, Leysalle A, Chamorey E, Borchiellini D. Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey. Ann Oncol. 2021;32(5):673–674. doi:10.1016/j.annonc.2021.01.066.
   PubMed Web of Science ®Google Scholar
• Zheng W, Sun Y, Li H, Zhao H, Zhan Y, Gao Y, Hu Y, Li P, Lin Y-F, Chen H, et al. COVID-19 vaccine uptake and hesitancy among HIV-infected men who have sex with men in mainland China: a cross-sectional survey. Hum Vaccines Immunotherapeutics. 2021 Dec 2;17(12):4971–4981. doi:10.1080/21645515.2021.1996152.
   PubMed Web of Science ®Google Scholar
• Brodziak A, Sigorski D, Osmola M, Wilk M, Gawlik-Urban A, Kiszka J, Machulska-Ciuraj K, Sobczuk P. Attitudes of patients with cancer towards vaccinations—results of online survey with special focus on the vaccination against COVID-19. Vaccines. 2021 Apr 21;9(5). doi:10.3390/vaccines9050411.
   Web of Science ®Google Scholar
• Kelkar AH, Blake JA, Cherabuddi K, Cornett H, McKee BL, Cogle CR. Vaccine enthusiasm and hesitancy in cancer patients and the impact of a webinar. Healthcare (Basel, Switzerland). 2021 Mar 19;9(3). doi:10.3390/healthcare9030351.
   PubMedGoogle Scholar
• Khiari H, Cherif I, M’Ghirbi F, Mezlini A, Hsairi M. COVID-19 vaccination Acceptance and its associated factors among cancer patients in Tunisia. Asian Pac J Cancer Prev. 2021 Nov 1;22(11):3499–3506. doi:10.31557/apjcp.2021.22.11.3499.
   PubMedGoogle Scholar
• Matovina Brko G, Popovic M, Jovic M, et al. COVID-19 vaccines and cancer patients: acceptance, attitudes and safety. J Buon. 2021;26(5):2183–2190.
   PubMedGoogle Scholar
• Tadele Admasu F. Knowledge and proportion of COVID-19 vaccination and associated factors among cancer patients attending public hospitals of addis ababa, Ethiopia, 2021: a multicenter study. Infect Drug Resist. 2021;14:4865–4876. doi: 10.2147/idr.S340324.
   PubMed Web of Science ®Google Scholar
• Chun JY, Kim SI, Park EY, Park S-Y, Koh S-J, Cha Y, Yoo HJ, Joung JY, Yoon HM, Eom BW, et al. Cancer patients’ willingness to take COVID-19 vaccination: a nationwide multicenter survey in Korea. Cancers. 2021 Aug 1;13(15):3883. doi:10.3390/cancers13153883.
   PubMed Web of Science ®Google Scholar
• Poeppl W, Lagler H, Raderer M, Sperr WR, Zielinski C, Herkner H, Burgmann H. Influenza vaccination perception and coverage among patients with malignant disease. Vaccine. 2015;33(14):1682–1687. doi:10.1016/j.vaccine.2015.02.029.
   PubMed Web of Science ®Google Scholar
• Khubchandani J, Sharma S, Price JH, Wiblishauser MJ, Sharma M, Webb FJ. COVID-19 vaccination hesitancy in the United States: a rapid national assessment. J Community Health. 2021;46(2):270–277. doi:10.1007/s10900-020-00958-x.
   PubMed Web of Science ®Google Scholar
• Fisher KA, Bloomstone SJ, Walder J, Crawford S, Fouayzi H, Mazor KM. Attitudes toward a potential SARS-CoV-2 vaccine : a survey of U.S. adults. Ann Intern Med. 2020 Dec 15;173(12):964–973. doi:10.7326/m20-3569.
   PubMed Web of Science ®Google Scholar
• Webb FJ, Khubchandani J, Striley CW, Cottler LB. Black-White differences in willingness to participate and perceptions about health research: results from the population-based health street study. J Immigrant Minority Health. 2019 Apr;21(2):299–305. doi:10.1007/s10903-018-0729-2.
   PubMed Web of Science ®Google Scholar
• Ferdinand KC, Nedunchezhian S, Reddy TK. The COVID-19 and influenza “twindemic”: barriers to influenza vaccination and potential acceptance of SARS-CoV2 vaccination in African Americans. J Natl Med Assoc. 2020;112(6):681–687. doi:10.1016/j.jnma.2020.11.001.
   PubMed Web of Science ®Google Scholar
• Quinn SC, Jamison AM, Freimuth V. Communicating effectively about emergency use authorization and vaccines in the COVID-19 pandemic. Am J Public Health. 2021;111(3):355–358. doi:10.2105/ajph.2020.306036.
   PubMed Web of Science ®Google Scholar
• Johannesen TB, Smeland S, Aaserud S, Buanes EA, Skog A, Ursin G, Helland Å. COVID-19 in cancer patients, risk factors for disease and adverse outcome, a population-based study from Norway. Front Oncol. 2021;11:652535. doi:10.3389/fonc.2021.652535.
   PubMedGoogle Scholar
• Tran S, Truong TH, Narendran A. Evaluation of COVID-19 vaccine response in patients with cancer: an interim analysis. Eur J Cancer. 2021;159:259–274. doi:10.1016/j.ejca.2021.10.013.
   PubMed Web of Science ®Google Scholar
• Monin L, Laing AG, Muñoz-Ruiz M, McKenzie DR, Del Molino Del Barrio I, Alaguthurai T, Domingo-Vila C, Hayday TS, Graham C, Seow J, et al. Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study. Lancet Oncol. 2021;22(6):765–778. doi:10.1016/s1470-2045(21)00213-8.
   PubMed Web of Science ®Google Scholar
• Massarweh A, Eliakim-Raz N, Stemmer A, Levy-Barda A, Yust-Katz S, Zer A, Benouaich-Amiel A, Ben-Zvi H, Moskovits N, Brenner B, et al. Evaluation of seropositivity following BNT162b2 messenger RNA vaccination for SARS-CoV-2 in patients undergoing treatment for Cancer. JAMA Oncol. 2021 Aug 1;7(8):1133–1140. doi:10.1001/jamaoncol.2021.2155.
   PubMed Web of Science ®Google Scholar
• Palich R, Veyri M, Marot S, Vozy A, Gligorov J, Maingon P, Marcelin A-G, Spano J-P. Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients. Ann Oncol. 2021;32(8):1051–1053. doi:10.1016/j.annonc.2021.04.020.
   PubMed Web of Science ®Google Scholar
• Guven DC, Sahin TK, Kilickap S, Uckun FM. Antibody responses to COVID-19 vaccination in Cancer: a systematic review. Front Oncol. 2021;11:759108. doi:10.3389/fonc.2021.759108.
   PubMed Web of Science ®Google Scholar
• So ACP, McGrath H, Ting J, Srikandarajah K, Germanou S, Moss C, Russell B, Monroy-Iglesias M, Dolly S, Irshad S, et al. COVID-19 vaccine safety in Cancer patients: a single centre experience. Cancers. 2021 July 16;13(14). doi:10.3390/cancers13143573.
   Web of Science ®Google Scholar
• Waissengrin B, Agbarya A, Safadi E, Padova H, Wolf I. Short-Term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors. Lancet Oncol. 2021;22(5):581–583. doi:10.1016/s1470-2045(21)00155-8.
   PubMed Web of Science ®Google Scholar